Introduction
Whipple's disease, a rare systemic infection caused by Tropheryma whipplei, involves the small intestine, leading to severe malabsorption. Only a few cases have been reported in Asian populations (1) . We herein describe the first Japanese case with Whipple's disease diagnosed by electron microscopy and polymerase chain reaction (PCR).
Case Report
In July 2003, a 52-year-old Japanese man presented with watery diarrhea, weight loss, and low-grade intermittent fever of one-year duration. He lost 20-kg during this period. His past medical history was unremarkable. He denied arthralgia, or neurologic symptoms. On examination, he had hyperpigmentation of light-exposed skin. His pulmonary and cardiac sounds were normal. There was no tenderness of the abdomen with increased bowel sound. No neurological abnormalities and lymphadenopathy were present. Laboratory data on admission is summarized in Table 1 , showing anemia and marked hypoalbuminemia. Colonoscopy showed normal findings. Enteroscopy showed diffuse yellow-white shaggy mucosa in the descending duodenum extending as far as the jejunum (Fig. 1A, B ). Biopsies stained with hematoxylin and eosin showed clubbed epithelial villi and foamy macrophages ( Fig. 2A) . Periodic acid-Schiff (PAS) staining revealed massive infiltration within the lamina propria by foamy macrophages (Fig. 2B ). Electron micrograph of the duodenal mucosa disclosed numerous extracellular bacilli and phagosome-containing bacilli within a macrophage (Fig.  3A, B) . PCR was performed to identify these bacilli according to the method using specific primers W3AF and W4AR established by Ramzan et al (2) . DNA from duodenal mucosa showed a specific PCR-product of 160 base pairs demonstrating homology with the T. whipplei 16S ribosomal RNA gene (Fig. 4) . Based on characteristic pathological and molecular findings, the definitive diagnosis of Whipple's disease was made. The patient was treated with a two-week course of ceftriaxone (2 g per day, intravenously), followed by trimethoprim-sulfamethoxazole (TMP-SMX, 4 g per day, orally). He responded dramatically with a rapid clinical remission. He has been free from symptoms and gained weight during the follow-up with the continuous administration of TMP-SMX. 
Discussion
Whipple's disease, formally known as intestinal lipodystrophy, was first described by George H. Whipple in 1907 (3). Its bacterial origins were identified by transmission electron microscopy in the early 1960's, establishing the bacterial cause. Since the early 1990's, PCR assay for 16S rRNA genes has permitted the identification of the suspected causative bacteria (1, 4) . Culture of the bacillus had been an elusive goal until Raoult and colleagues succeeded by using a human fibroblast cell line in 2000 (5) . Surprisingly, the calculated doubling time of T. whipplei is 18 days, therefore, there is no wonder that culture of the bacteria is currently undertaken only in highly specialized laboratories (1). This disorder predominantly affects middle-aged Caucasian men; in fact, there has been only one case report in Japan according to the bibliographic search. The patient, whom Naramoto et al reported in 1976 (6), was suspected to have Whipple's disease by the demonstration of PAS-positive macrophages in the jejunal lamina propria. However, they failed to identify Whipple bacillus in the intestinal samples by electron microscopy. Due to the previous inability to culture the Whipple bacillus, PAS staining was considered the main tool for diagnosing Whipple's disease (7) . However, because detection of PAS-positive macrophages is also seen in other diseases including infection with Mycobacterium aviumintracellulare, Bacillus cereus, or corynebacterium (1), nowadays confirmation by electron microscopy and PCR assay are mandatory for definitive diagnosis (1, 3) . Thus, the present case is the first Japanese patient with Whipple's disease diagnosed by electron microscopy and PCR.
The infectious route of T. whipplei remains unclear. Detection of the bacterium by PCR in sewage water and human feces in Europe has led to speculation of its existence in the environment (1) . Other research has demonstrated that 35% of 40 healthy people showed evidence of T. whipplei DNA in their saliva, suggesting this bacterium can be an oral commensal (8) . The detection rate may vary geographically; therefore, we should further study PCR detection of the bacterium in the saliva of patient's family members and the surrounding environment. Moreover, genomic studies have been in progress to clarify the link between genotype and symptom pattern (9) .
The pathogenesis of Whipple's disease by T. whipplei is not fully understood. Marth and colleagues (1, 10) showed that a defective cellular immune response in a large series of Whipple's disease patients and an important pathogenic role of impaired T-helper cells of type 1 (Th1) responses with reduced production of interleukin (IL)-12 and interferon (IFN)-and subsequent decreased activation of macrophages. The present patient was infected with both T. whipplei and human T-cell lymphotropic virus type I (HTLV-I). The patient was born and has lived in Okinawa, a well-studied endemic region of HTLV-I. Most individuals chronically infected with HTLV-I remain asymptomatic; however, some of them may have a significant form of chronic immune suppression and, as a consequence, this affects the risk of other infectious diseases including strongyloidiasis and tuberculosis (11) . Increasing evidence has indicated the immune deviation toward Th1 with a high production of IL-2, IL-12, and IFN-in the asymptomatic state and early immunopathogenesis of HTLV-I infection (12, 13) . Therefore, the hypothesis of Th1/Th2 balance fails to explain solely this complicated pathogenesis whether or not coinfection with HTLV-I involves the onset of Whipple's disease in our case. Other unknown mechanisms of immune suppression may be associated with the development of the disease. Further immunological studies are necessary to clarify this immunopathogenesis.
Because Whipple's disease is uncommon, prospective evaluations of therapeutic regimens have not been established. We therefore followed the currently recommended regimens described in a review article (1) . Although most patients respond well, some patients with relapse have a poor outlook (1). In addition, regression of histopathological findings seems slower and PAS-positive structures may persist for years (3) . We therefore should follow-up the patient with electron microscopy and PCR. In conclusion, although extremely rare in Asia, Whipple's disease should be included in a differential diagnosis for the management of chronic diarrhea. 
